Ignite Creation Date:
2024-05-06 @ 3:55 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04801381
Status:
RECRUITING
Last Update Posted:
2023-05-11
First Post:
2021-03-10
Brief Title:
WATER III Aquablation vs Transurethral Laser Enucleation of Large Prostates 80 - 180mL in Benign Prostatic Hyperplasia
Sponsor:
University of Bonn
Organization:
University of Bonn
Study Overview
Official Title:
WATER III Aquablation vs Transurethral Laser Enucleation of Large Prostates 80-180ml in Benign Prostatic Hyperplasia
Status:
RECRUITING
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
WATER III
Brief Summary:
Comparative analysis of efficacy and safety of Aquablation AQUABEAM Robotic System PROCEPT BioRobotics Redwood City CA USA and transurethral laser enucleation as surgical therapy for benign prostatic hyperplasia with large prostates 80-180ml
Detailed Description:
Prospective randomized and non-randomized cohort two-arm multicenter trial two arm multicenter trial to evaluate the efficacy and safety of Aquablation AQUABEAM Robotic System PROCEPT BioRobotics Redwood City CA USA compared to transurethral laser enucleation - the current reference standard of minimal invasive therapy for benign prostatic hyperplasia in large prostates 80-180ml
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None